Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study).
Tamura N, Azuma T, Misaki K, Yamaguchi R, Hirano F, Sugiyama E, Kanai D, Murakawa Y, Oribe M, Kimata T, Aoki K, Sugiura T, Takasugi K, Takakubo Y, Tomita Y, Isozaki T, Nanki T, Katsuyama N, Kuroiwa T, Oshikawa H, Kaneko M, Fujinaga H, Saito K, Tanaka E, Inoue E, Yoshizawa Y, Matsumoto S, Yamanaka H, Harigai M. Tamura N, et al. Among authors: oshikawa h. Mod Rheumatol. 2022 Aug 20;32(5):846-856. doi: 10.1093/mr/roab090. Mod Rheumatol. 2022. PMID: 34915575
An observational study of tocilizumab and TNF-α inhibitor use in a Japanese community hospital: different remission rates, similar drug survival and safety.
Yoshida K, Tokuda Y, Oshikawa H, Utsunomiya M, Kobayashi T, Kimura M, Deshpande GA, Matsui K, Kishimoto M. Yoshida K, et al. Among authors: oshikawa h. Rheumatology (Oxford). 2011 Nov;50(11):2093-9. doi: 10.1093/rheumatology/ker295. Epub 2011 Sep 2. Rheumatology (Oxford). 2011. PMID: 21890622 Free PMC article.
Factors contributing to the improvement in J-HAQ after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long-term, observational, multicentre study in Japan (ORIGAMI).
Misaki K, Tanaka E, Inoue E, Tamura N, Hirano F, Taniguchi Y, Sato H, Naniwa T, Oshikawa H, Yoshitama T, Takakubo Y, Suzuki Y, Himeno S, Tsuritani K, Matsumoto S, Yamanaka H, Harigai M. Misaki K, et al. Among authors: oshikawa h. Mod Rheumatol. 2024 May 10:roae043. doi: 10.1093/mr/roae043. Online ahead of print. Mod Rheumatol. 2024. PMID: 38727535
Differences in clinical manifestations, treatment, and concordance rates with two major sets of criteria for Behçet's syndrome for patients in the US and Japan: data from a large, three-center cohort study.
Kobayashi T, Kishimoto M, Swearingen CJ, Filopoulos MT, Ohara Y, Tokuda Y, Oshikawa H, Yoshida K, Utsunomiya M, Kimura M, Okada M, Matsui K, Yazici Y. Kobayashi T, et al. Among authors: oshikawa h. Mod Rheumatol. 2013 May;23(3):547-53. doi: 10.1007/s10165-012-0696-8. Epub 2012 Jun 30. Mod Rheumatol. 2013. PMID: 22752504
A graphic demonstration that the Disease Activity Score in 28 joints using the erythrocyte sedimentation rate is overly sensitive when erythrocyte sedimentation rates are low: Comment on the article by Smolen and Aletaha.
Yoshida K, Matsui K, Oshikawa H, Utsunomiya M, Kobayashi T, Kimura M, Deshpande GA, Kishimoto M. Yoshida K, et al. Among authors: oshikawa h. Arthritis Rheum. 2011 Jul;63(7):2149; author reply 2149-50. doi: 10.1002/art.30370. Arthritis Rheum. 2011. PMID: 21452296 Free article. No abstract available.
16 results